3billion at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

3billion at BIO-Europe 2026 in Cologne: 1 session (1 talk).

OrganizationBIO-Europe 2026 Attendance
3billion
Seoul, South Korea
Biotech
Rare-disease genetic testing company whose genome analysis is re-run as new disease genes are described, until a patient is diagnosed.
Talk
Mon Nov 9
15:15–15:30
Drug Discovery and Development: 3billion
How a rare disease genetic testing company is using its large store of genome and patient data to find drug targets with AI.

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from 3billion

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction